In patients post myocardial infarct, GLP-1 infusion resulted in improvement in systolic function [69], and treatment with GLP1RAs resulted in decreased myocardial infarct size [70,71] and improvement in left ventricular function [72]
100% SYNTHETIC All products synthetically manufactured, zero animal derivatives
& Klein, A
Lowest effective dose tailored to you Fewer side effects minimal nausea, fatigue Better protein intake & muscle preservation Dose adjusted based on labs & response Hormone & root-cause investigation Built-in exit strategy from medication Sustainable, long-term results Fixed escalation regardless of response More nausea, vomiting, fatigue Significant muscle loss reported No labs, no individual monitoring Hormones & root causes never addressed No plan to come off medication Weight regain when medication stops How the 12-Week Program Works From your first consultation to your final follow-up, every step is designed to produce lasting results
Thank you to Mike Lawson for the platform and to Tom for being such a compelling voice for what's possible when technology and people work together the right way
Two major factors we see repeatedly are metabolism changes and hormonal shifts